US 12,226,415 B2
Methods and compositions for the treatment of hair loss
John Edward Wurst, Poway, CA (US)
Assigned to Aneira Pharma, Inc., San Diego, CA (US)
Appl. No. 17/632,973
Filed by Aneira Pharma Inc., San Diego, CA (US)
PCT Filed Aug. 3, 2020, PCT No. PCT/US2020/044771
§ 371(c)(1), (2) Date Feb. 4, 2022,
PCT Pub. No. WO2021/026084, PCT Pub. Date Feb. 11, 2021.
Claims priority of provisional application 63/100,611, filed on Mar. 23, 2020.
Claims priority of provisional application 62/895,869, filed on Sep. 4, 2019.
Claims priority of provisional application 62/883,809, filed on Aug. 7, 2019.
Prior Publication US 2022/0288090 A1, Sep. 15, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61P 17/14 (2006.01); A61K 9/00 (2006.01); A61K 31/222 (2006.01); A61K 31/25 (2006.01); A61K 31/506 (2006.01); A61K 31/5575 (2006.01); A61K 31/58 (2006.01); A61K 38/13 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01)
CPC A61K 31/506 (2013.01) [A61K 9/0014 (2013.01); A61K 31/222 (2013.01); A61K 31/25 (2013.01); A61K 31/5575 (2013.01); A61K 31/58 (2013.01); A61K 38/13 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61P 17/14 (2018.01)] 10 Claims
 
1. A composition for use in the treatment of hair loss comprising about 0.05%-0.5% w/v latanoprost and latanoprost acid and 0.01%-0.1% w/v cyclosporine.